Reagents, Treponemal (syphilis), RDT (Rapid Diagnostic Test)

Primary use
Diagnosis / Measurement / Monitoring
Type of medical device or related product
Solutions and reagents
Multiple vs. specific use (health condition)
Multiple
Intended population age
Later adults (over 64 years)
Adults (20 to 64 years)
Intended population sex
All
Level of technical knowledge
Specialized clinical
Capital
No
Reusable
Yes
Requirements
None
WHO list of priority medical devices
Reproductive, maternal, newborn and child health (2015)
Service delivery platforms / Healthcare levels
First-level (district) hospital services
General outpatient (health post, health center) and outreach services for primary care
Second-level and third-level hospital services and specialized outpatient services
Healthcare unit
Emergency care
Inpatient care
Intensive care
Laboratory
Outpatient care
EMDN related code(s)
W01050103
SYPHILIS (TREPONEMA PALLIDUM)
The code(s) and term(s) in this section were observed and retrieved from public databases and have not been validated by health regulatory authorities. Please consult your regulatory agency and EMDN site: https://webgate.ec.europa.eu/dyna2/emdn
GMDN related code(s)
51803
Treponema pallidum total antibody IVD, reagent (A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of total antibodies to Treponema pallidum bacteria in a clinical specimen.)
The medical device term(s), code(s) and definition(s) in this section were retrieved from databases external to WHO. As there might be more than one name, definition and “Nomenclature Code” related to the specific medical device, please consult https://gmdnagency.org GMDN ®. © GMDN Agency 2005-2025 
WHO related resources
Decommissioning
WHO resources on medical devices